DMII — DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 71 家机构在其最新 13F 申报中持有 DMII(DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00),合计申报市值 $492.18M,对应 48.92M 股。按股数计算较上季度增持 6.7%(+3.00M 股),申报市值环比上升 7.7%。持仓集中度较高:前五大持有人占申报市值的 26.1%,前十大的集中度为 45.1%。
与上一季度相比,7 家新建仓位、17 家加仓、12 家减仓、6 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00(DMII)的主要机构持有人包括 Karpus Management, Inc.、Magnetar Financial LLC、MMCAP International Inc. SPC,按 13F 申报市值在本页 80 家持有人中排名居前。
DMII 属于Financials板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 35 | 22.82M | $232.43M | +1.5% |
| Q2 2026 | 71 | 48.92M | $492.18M | +6.7% |
| Q1 2026 | 70 | 47.29M | $471.70M | +4.9% |
| Q4 2025 | 53 | 37.22M | $367.64M | — |
表内 4 个季度中,机构持股合计减少 39%(Q4 2025 → Q3 2026);单季变动最大的是 Q2 2026(+6.7%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
新建仓(Q2 2026)
- TIG Advisors, LLC 500.00K 股 · $5.03M
- CANTOR FITZGERALD, L. P. 363.10K 股 · $3.65M
- SkyView Investment Advisors, LLC 250.00K 股 · $2.52M
- Kepos Capital LP 210.00K 股 · $2.11M
- Arax Advisory Partners 65.99K 股 · $663.86K
- GEODE CAPITAL MANAGEMENT, LLC 39.65K 股 · $398.87K
- Tuttle Capital Management, LLC 10.77K 股 · $108.34K
完全清仓(较上季)
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 卖出 2.00M 股 · $19.96M
- Sculptor Capital LP 卖出 500.00K 股 · $4.99M
- Parallax Volatility Advisers, L.P. 卖出 133.65K 股 · $1.34M
- CSS LLC/IL 卖出 110.04K 股 · $1.10M
- DELTEC ASSET MANAGEMENT LLC 卖出 50.00K 股 · $498.50K
- MIZUHO SECURITIES USA LLC 卖出 18.60K 股 · $184.14K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|---|
| Karpus Management, Inc. | 3.30M | 2.79M | 2.60M | 1.14M |
| Magnetar Financial LLC | 2.70M | 2.70M | 2.70M | 2.70M |
| MMCAP International Inc. SPC | 2.70M | 2.70M | 2.70M | — |
| Hudson Bay Capital Management LP | 1.97M | 1.97M | 1.97M | 1.97M |
| WOLVERINE ASSET MANAGEMENT LLC | 1.84M | 1.86M | 1.80M | 1.06M |
| First Trust Capital Management L.P. | 1.30M | 1.07M | 1.07M | 2.07M |
| Crossingbridge Advisors, LLC | 1.10M | 1.10M | 350.00K | — |
| OMERS ADMINISTRATION Corp | 1.00M | 1.00M | 1.00M | 1.00M |
| PICTON MAHONEY ASSET MANAGEMENT | 888.00K | 888.00K | 875.00K | 875.00K |
| Westchester Capital Management, LLC | 771.80K | 621.80K | 500.01K | 500.00K |
| Mercuria Capital Strategies, LLC | 750.00K | 750.00K | 750.00K | — |
| Context Capital Management, LLC | 749.61K | 750.00K | 750.00K | 750.00K |
| HighTower Advisors, LLC | 546.61K | 566.61K | 714.61K | 789.61K |
| BlueCrest Capital Management Ltd | 500.00K | 500.00K | 500.00K | — |
| Wealthspring Capital LLC | 399.15K | 400.44K | 402.67K | 408.95K |
| BNP PARIBAS FINANCIAL MARKETS | 394.95K | 394.95K | 394.95K | 348.60K |
| Mint Tower Capital Management B.V. | 250.00K | 250.00K | 250.00K | 250.00K |
| Kepos Capital LP | 210.00K | 210.00K | — | — |
| Verition Fund Management LLC | 202.84K | 202.84K | 202.84K | 200.00K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 179.50K | 179.50K | 179.50K | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold DMII?
As of 2026-Q2, 71 institutional funds reported holding DMII (DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00) in SEC 13F filings, with a combined reported value of $492.18M.
How many shares of DMII do institutions own?
13F filers reported 48.92M shares of DMII, worth $492.18M in aggregate at the end of 2026-Q2.
Is institutional ownership of DMII rising or falling?
Share counts moved +6.7% versus the prior quarter — accumulation.
Who are the top institutional holders of DMII?
The largest 13F holders are Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, GLAZER CAPITAL, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00?
The major shareholders of DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00 (DMII) by reported 13F value are Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, GLAZER CAPITAL, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 80 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.